Lung Cancer, Nonsmall Cell, Stage I Not Yet Recruiting Phase 1 / 2 Trials for Durvalumab (DB11714)

Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I

IndicationStatusPhase
DBCOND0081601 (Lung Cancer, Nonsmall Cell, Stage I)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05451173Combining ICI With SBRT or HypoFrx-RT for ES NSCLCTreatment